United States Controlled Release Drug Market Report 2017

United States Controlled Release Drug Market Report 2017

1 Controlled Release Drug Overview

1.1 Product Overview and Scope of Controlled Release Drug

1.2 Classification of Controlled Release Drug by Product Category

1.2.1 United States Controlled Release Drug Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Controlled Release Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Pills

1.2.4 Capsules

1.2.5 Injectable Drug Carriers

1.2.6 Others

1.3 United States Controlled Release Drug Market by Application/End Users

1.3.1 United States Controlled Release Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Respiratory disease

1.3.3 Digestive Disease

1.3.4 Others

1.4 United States Controlled Release Drug Market by Region

1.4.1 United States Controlled Release Drug Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Controlled Release Drug Status and Prospect (2012-2022)

1.4.3 Southwest Controlled Release Drug Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Controlled Release Drug Status and Prospect (2012-2022)

1.4.5 New England Controlled Release Drug Status and Prospect (2012-2022)

1.4.6 The South Controlled Release Drug Status and Prospect (2012-2022)

1.4.7 The Midwest Controlled Release Drug Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Controlled Release Drug (2012-2022)

1.5.1 United States Controlled Release Drug Sales and Growth Rate (2012-2022)

1.5.2 United States Controlled Release Drug Revenue and Growth Rate (2012-2022)

2 United States Controlled Release Drug Market Competition by Players/Suppliers

2.1 United States Controlled Release Drug Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Controlled Release Drug Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Controlled Release Drug Average Price by Players/Suppliers (2012-2017)

2.4 United States Controlled Release Drug Market Competitive Situation and Trends

2.4.1 United States Controlled Release Drug Market Concentration Rate

2.4.2 United States Controlled Release Drug Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Controlled Release Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Controlled Release Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Controlled Release Drug Sales and Market Share by Region (2012-2017)

3.2 United States Controlled Release Drug Revenue and Market Share by Region (2012-2017)

3.3 United States Controlled Release Drug Price by Region (2012-2017)

4 United States Controlled Release Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Controlled Release Drug Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Controlled Release Drug Revenue and Market Share by Type (2012-2017)

4.3 United States Controlled Release Drug Price by Type (2012-2017)

4.4 United States Controlled Release Drug Sales Growth Rate by Type (2012-2017)

5 United States Controlled Release Drug Sales (Volume) by Application (2012-2017)

5.1 United States Controlled Release Drug Sales and Market Share by Application (2012-2017)

5.2 United States Controlled Release Drug Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Controlled Release Drug Players/Suppliers Profiles and Sales Data

6.1 Allergan

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Controlled Release Drug Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Allergan Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 BioAlliance Pharma

6.2.2 Controlled Release Drug Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 BioAlliance Pharma Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Collegium Pharmaceutical

6.3.2 Controlled Release Drug Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Collegium Pharmaceutical Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Controlled Therapeutics

6.4.2 Controlled Release Drug Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Controlled Therapeutics Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Cosmo Pharmaceuticals

6.5.2 Controlled Release Drug Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Cosmo Pharmaceuticals Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Egalet

6.6.2 Controlled Release Drug Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Egalet Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Encore Therapeutics

6.7.2 Controlled Release Drug Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Encore Therapeutics Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Flamel Technologies

6.8.2 Controlled Release Drug Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Flamel Technologies Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 GlaxoSmithKline

6.9.2 Controlled Release Drug Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 GlaxoSmithKline Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 iCeutica

6.10.2 Controlled Release Drug Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 iCeutica Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Novartis

6.12 Pfizer

7 Controlled Release Drug Manufacturing Cost Analysis

7.1 Controlled Release Drug Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Controlled Release Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Controlled Release Drug Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Controlled Release Drug Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Controlled Release Drug Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Controlled Release Drug Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Controlled Release Drug Sales Volume Forecast by Type (2017-2022)

11.3 United States Controlled Release Drug Sales Volume Forecast by Application (2017-2022)

11.4 United States Controlled Release Drug Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Controlled Release Drug

Figure United States Controlled Release Drug Market Size (K Pcs) by Type (2012-2022)

Figure United States Controlled Release Drug Sales Volume Market Share by Type (Product Category) in 2016

Figure Pills Product Picture

Figure Capsules Product Picture

Figure Injectable Drug Carriers Product Picture

Figure Others Product Picture

Figure United States Controlled Release Drug Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of Controlled Release Drug by Application in 2016

Figure Respiratory disease Examples

Table Key Downstream Customer in Respiratory disease

Figure Digestive Disease Examples

Table Key Downstream Customer in Digestive Disease

Figure Others Examples

Table Key Downstream Customer in Others

Figure United States Controlled Release Drug Market Size (Million USD) by Region (2012-2022)

Figure The West Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Controlled Release Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States Controlled Release Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States Controlled Release Drug Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Controlled Release Drug Sales Share by Players/Suppliers

Figure 2017 United States Controlled Release Drug Sales Share by Players/Suppliers

Figure United States Controlled Release Drug Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Controlled Release Drug Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Controlled Release Drug Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Controlled Release Drug Revenue Share by Players/Suppliers

Figure 2017 United States Controlled Release Drug Revenue Share by Players/Suppliers

Table United States Market Controlled Release Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market Controlled Release Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States Controlled Release Drug Market Share of Top 3 Players/Suppliers

Figure United States Controlled Release Drug Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Controlled Release Drug Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Controlled Release Drug Product Category

Table United States Controlled Release Drug Sales (K Pcs) by Region (2012-2017)

Table United States Controlled Release Drug Sales Share by Region (2012-2017)

Figure United States Controlled Release Drug Sales Share by Region (2012-2017)

Figure United States Controlled Release Drug Sales Market Share by Region in 2016

Table United States Controlled Release Drug Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Controlled Release Drug Revenue Share by Region (2012-2017)

Figure United States Controlled Release Drug Revenue Market Share by Region (2012-2017)

Figure United States Controlled Release Drug Revenue Market Share by Region in 2016

Table United States Controlled Release Drug Price (USD/Pcs) by Region (2012-2017)

Table United States Controlled Release Drug Sales (K Pcs) by Type (2012-2017)

Table United States Controlled Release Drug Sales Share by Type (2012-2017)

Figure United States Controlled Release Drug Sales Share by Type (2012-2017)

Figure United States Controlled Release Drug Sales Market Share by Type in 2016

Table United States Controlled Release Drug Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Controlled Release Drug Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Controlled Release Drug by Type (2012-2017)

Figure Revenue Market Share of Controlled Release Drug by Type in 2016

Table United States Controlled Release Drug Price (USD/Pcs) by Types (2012-2017)

Figure United States Controlled Release Drug Sales Growth Rate by Type (2012-2017)

Table United States Controlled Release Drug Sales (K Pcs) by Application (2012-2017)

Table United States Controlled Release Drug Sales Market Share by Application (2012-2017)

Figure United States Controlled Release Drug Sales Market Share by Application (2012-2017)

Figure United States Controlled Release Drug Sales Market Share by Application in 2016

Table United States Controlled Release Drug Sales Growth Rate by Application (2012-2017)

Figure United States Controlled Release Drug Sales Growth Rate by Application (2012-2017)

Table Allergan Basic Information List

Table Allergan Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Allergan Controlled Release Drug Sales Growth Rate (2012-2017)

Figure Allergan Controlled Release Drug Sales Market Share in United States (2012-2017)

Figure Allergan Controlled Release Drug Revenue Market Share in United States (2012-2017)

Table BioAlliance Pharma Basic Information List

Table BioAlliance Pharma Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure BioAlliance Pharma Controlled Release Drug Sales Growth Rate (2012-2017)

Figure BioAlliance Pharma Controlled Release Drug Sales Market Share in United States (2012-2017)

Figure BioAlliance Pharma Controlled Release Drug Revenue Market Share in United States (2012-2017)

Table Collegium Pharmaceutical Basic Information List

Table Collegium Pharmaceutical Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Collegium Pharmaceutical Controlled Release Drug Sales Growth Rate (2012-2017)

Figure Collegium Pharmaceutical Controlled Release Drug Sales Market Share in United States (2012-2017)

Figure Collegium Pharmaceutical Controlled Release Drug Revenue Market Share in United States (2012-2017)

Table Controlled Therapeutics Basic Information List

Table Controlled Therapeutics Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Controlled Therapeutics Controlled Release Drug Sales Growth Rate (2012-2017)

Figure Controlled Therapeutics Controlled Release Drug Sales Market Share in United States (2012-2017)

Figure Controlled Therapeutics Controlled Release Drug Revenue Market Share in United States (2012-2017)

Table Cosmo Pharmaceuticals Basic Information List

Table Cosmo Pharmaceuticals Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Cosmo Pharmaceuticals Controlled Release Drug Sales Growth Rate (2012-2017)

Figure Cosmo Pharmaceuticals Controlled Release Drug Sales Market Share in United States (2012-2017)

Figure Cosmo Pharmaceuticals Controlled Release Drug Revenue Market Share in United States (2012-2017)

Table Egalet Basic Information List

Table Egalet Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Egalet Controlled Release Drug Sales Growth Rate (2012-2017)

Figure Egalet Controlled Release Drug Sales Market Share in United States (2012-2017)

Figure Egalet Controlled Release Drug Revenue Market Share in United States (2012-2017)

Table Encore Therapeutics Basic Information List

Table Encore Therapeutics Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Encore Therapeutics Controlled Release Drug Sales Growth Rate (2012-2017)

Figure Encore Therapeutics Controlled Release Drug Sales Market Share in United States (2012-2017)

Figure Encore Therapeutics Controlled Release Drug Revenue Market Share in United States (2012-2017)

Table Flamel Technologies Basic Information List

Table Flamel Technologies Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Flamel Technologies Controlled Release Drug Sales Growth Rate (2012-2017)

Figure Flamel Technologies Controlled Release Drug Sales Market Share in United States (2012-2017)

Figure Flamel Technologies Controlled Release Drug Revenue Market Share in United States (2012-2017)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure GlaxoSmithKline Controlled Release Drug Sales Growth Rate (2012-2017)

Figure GlaxoSmithKline Controlled Release Drug Sales Market Share in United States (2012-2017)

Figure GlaxoSmithKline Controlled Release Drug Revenue Market Share in United States (2012-2017)

Table iCeutica Basic Information List

Table iCeutica Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure iCeutica Controlled Release Drug Sales Growth Rate (2012-2017)

Figure iCeutica Controlled Release Drug Sales Market Share in United States (2012-2017)

Figure iCeutica Controlled Release Drug Revenue Market Share in United States (2012-2017)

Table Novartis Basic Information List

Table Pfizer Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Controlled Release Drug

Figure Manufacturing Process Analysis of Controlled Release Drug

Figure Controlled Release Drug Industrial Chain Analysis

Table Raw Materials Sources of Controlled Release Drug Major Players/Suppliers in 2016

Table Major Buyers of Controlled Release Drug

Table Distributors/Traders List

Figure United States Controlled Release Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Controlled Release Drug Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States Controlled Release Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Controlled Release Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Controlled Release Drug Sales Volume (K Pcs) Forecast by Type in 2022

Table United States Controlled Release Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Controlled Release Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Controlled Release Drug Sales Volume (K Pcs) Forecast by Application in 2022

Table United States Controlled Release Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States Controlled Release Drug Sales Volume Share Forecast by Region (2017-2022)

Figure United States Controlled Release Drug Sales Volume Share Forecast by Region (2017-2022)

Figure United States Controlled Release Drug Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources